Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Clinical Immunology
|
October 6, 2010
IVIg attenuates TLR-9 activation in B cells from SLE patients
Aharon Kessel, Regina Peri, Tharwat Haj, et al.
The Israel Medical Association Journal : IMAJ
|
June 5, 2015
Interferon-gamma-release assay prevents unnecessary tuberculosis therapy
Vered Schichter-Konfino, Katalin Halasz, Galia Grushko, et al.
Stem Cells and Development
|
April 19, 2022
The Modulatory Effect of Adipose-Derived Stem Cells on Endometrial Polyp Fibroblasts
Reema Fadoul, Tharwat Haj Khalil, Idan Redenski, et al.
Arthritis Research & Therapy
|
June 16, 2012
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus
Zahava Vadasz, Tharwat Haj, Katalin Halasz, et al.
Rheumatology International
|
April 22, 2015
Semaphorin 3A: an immunoregulator in systemic sclerosis
Doron Rimar, Yuval Nov, Itzhak Rosner, et al.
International Journal of Molecular Sciences
|
December 30, 2025
Pro-Inflammatory Macrophage Phenotype Skewing Induced by Tumor Treating Fields (TTFields)
Tal Kan, Yiftah Barsheshet, Tharwat Haj Khalil, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 28, 2014
Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis
Doron Rimar, Itzhak Rosner, Yuval Nov, et al.
Frontiers in Medicine
|
February 26, 2021
COVID-19 Vaccine Acceptance Among Dental Professionals Based on Employment Status During the Pandemic
Asaf Zigron, Amiel A Dror, Nicole G Morozov, et al.
International Journal of Molecular Sciences
|
November 26, 2022
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model
Yiftah Barsheshet, Tali Voloshin, Boris Brant, et al.
International Journal of Cancer
|
February 27, 2026
Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxel
Tal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Clinical Immunology
|
October 6, 2010
IVIg attenuates TLR-9 activation in B cells from SLE patients
Aharon Kessel, Regina Peri, Tharwat Haj, et al.
The Israel Medical Association Journal : IMAJ
|
June 5, 2015
Interferon-gamma-release assay prevents unnecessary tuberculosis therapy
Vered Schichter-Konfino, Katalin Halasz, Galia Grushko, et al.
Stem Cells and Development
|
April 19, 2022
The Modulatory Effect of Adipose-Derived Stem Cells on Endometrial Polyp Fibroblasts
Reema Fadoul, Tharwat Haj Khalil, Idan Redenski, et al.
Arthritis Research & Therapy
|
June 16, 2012
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus
Zahava Vadasz, Tharwat Haj, Katalin Halasz, et al.
Rheumatology International
|
April 22, 2015
Semaphorin 3A: an immunoregulator in systemic sclerosis
Doron Rimar, Yuval Nov, Itzhak Rosner, et al.
International Journal of Molecular Sciences
|
December 30, 2025
Pro-Inflammatory Macrophage Phenotype Skewing Induced by Tumor Treating Fields (TTFields)
Tal Kan, Yiftah Barsheshet, Tharwat Haj Khalil, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 28, 2014
Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis
Doron Rimar, Itzhak Rosner, Yuval Nov, et al.
Frontiers in Medicine
|
February 26, 2021
COVID-19 Vaccine Acceptance Among Dental Professionals Based on Employment Status During the Pandemic
Asaf Zigron, Amiel A Dror, Nicole G Morozov, et al.
International Journal of Molecular Sciences
|
November 26, 2022
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model
Yiftah Barsheshet, Tali Voloshin, Boris Brant, et al.
International Journal of Cancer
|
February 27, 2026
Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxel
Tal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, et al.
Page
of 2